Get the Stockscreener App
6.17
1.98%
0.12
Capsovision Inc stock is traded at $6.17, with a volume of 216.89K.
It is up +1.98% in the last 24 hours and up +5.83% over the past month.
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
See More
Previous Close:
$6.05
Open:
$6.05
24h Volume:
216.89K
Relative Volume:
1.18
Market Cap:
$328.31M
Revenue:
$13.56M
Net Income/Loss:
$-26.97M
P/E Ratio:
-10.75
EPS:
-0.5742
Net Cash Flow:
$-24.04M
1W Performance:
-2.53%
1M Performance:
+5.83%
6M Performance:
-29.00%
1Y Performance:
+36.50%
1-Day Range:
$5.88
$6.19
1-Week Range:
$5.88
$6.91
52-Week Range:
$4.34
$15.37
Capsovision Inc Stock (CV) Company Profile
Name
Capsovision Inc
Sector
Industry
Phone
(408) 370-4790
Address
18805 COX AVENUE SUITE 250, SARATOGA
Compare CV vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
6.17 | 328.31M | 13.56M | -26.97M | -24.04M | -0.5742 |
ABT
Abbott Laboratories
|
101.07 | 174.89B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
88.51 | 113.22B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
269.75 | 103.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.68 | 64.75B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.73 | 49.41B | 6.30B | 1.07B | 1.09B | 1.8406 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-25 | Initiated | Roth Capital | Buy |
| Jul-28-25 | Initiated | The Benchmark Company | Speculative Buy |
Capsovision Inc Stock (CV) Latest News
Wednesday’s insider activity: Major buys at CapsoVision and sells at Diamondback - Investing.com
Wednesday’s insider activity: Major buys at CapsoVision and sells at Diamondback By Investing.com - Investing.com South Africa
CapsoVision Insider Bought Shares Worth $9,999,999, According to a Recent SEC Filing - marketscreener.com
Form 4 CapsoVision Inc For: 23 September By Investing.com - Investing.com India
CapsoVision director Eliyahou Harari buys $10 million in shares By Investing.com - Investing.com Canada
CapsoVision director Eliyahou Harari buys $10 million in shares - Investing.com
Form 4 CapsoVision For: 23 September By Investing.com - Investing.com Canada
CapsoVision, Inc.(NasdaqCM: CV) added to S&P Global BMI Index - marketscreener.com
CapsoVision, Inc. Stock Price Prediction: Today, Tomorrow, Next Week (CV) - Traders Union
ETFs Investing in CapsoVision, Inc. Stocks - TradingView
CapsoVision Announces $18 Million Direct Stock Offering - TipRanks
Three existing investors agree to buy $18M in new CapsoVision (NASDAQ: CV) shares - Stock Titan
Capsovision Offers 3.2 Million Shares For About $18.0 Million Gross Proceeds - tradingview.com
CapsoVision Currently Up Nine Consecutive Days, on Pace for Longest Winning Streak Since September 2025 -- Data Talk - Moomoo
David S. Shields is Named to CapsoVision’s Board - Medical Product Outsourcing
CapsoVision Announces Upcoming Investor Conference Participation for September 2026 - Quiver Quantitative
CapsoVision to Participate in Upcoming Investor Conferences - GlobeNewswire
CV Q2 2026 Earnings: Wider-than-Expected Loss Sets Cautious ToneEarnings Miss Alert - careplusvn.com
CapsoVision (CV) Price: Ends Up by 1.86% at $6.02 in the Current Update; Levels: Support at $5.72 and Resistance at $6.32 Frame the Range in the Available RecordSize Factor - vinanet.vn
CapsoVision (CV) Levels: Rises 1.86% to $6.02 for the Current Session; Price Setup: the Near-Term Reference Band Stretches From $5.72 to $6.32Channel Projection - vinanet.vn
CapsoVision (CV) Market: Ends Higher by 1.86% at $6.02 in the Latest Reading; Current Setup: the Supplied Trading Band Runs From $5.72 to $6.32 at the CloseLow Vol Factor - dars.gov.et
CapsoVision (CV) Earnings Update: The Bottom-Line Figure Trails Its Comparison; Latest Reaction: The Stock Ends Down 0.49%Basic EPS Analysis - vinanet.vn
CapsoVision Initiates $100 Million At-the-Market Equity Offering with Cantor Fitzgerald - Kalkine Media
CapsoVision Launches $100 Million At-The-Market Offering - TipRanks
CapsoVision launches $100M at-the-market equity program with Cantor Fitzgerald - TradingView
The CapsoVision, Inc. (NASDAQ:CV) Second-Quarter Results Are Out And Analysts Have Published New Forecasts - 富途牛牛
CapsoVision Earnings Call: Growth, AI Push, Margin Strain - TipRanks
CapsoVision stock rating maintained at Speculative Buy by Benchmark - Investing.com
CapsoVision (CV) Q2 2026 Earnings Call: Umsatz steigt um 10 %, KI-Einführung schreitet voran - TradingKey
CapsoVision Inc (CV) (Q2 2026) Earnings Call Highlights: AI Launch Drives Growth Amid Pricing ... By GuruFocus - Investing.com Canada
CapsoVision (CV) Stock Rich Valuation Meets Widening Losses - webull.com
CapsoVision Q2 Earnings Call Highlights - MarketBeat
CAPSOVISION ($CV) Releases Q2 2026 Earnings - Quiver Quantitative
CapsoVision Reports Q2 2026 Financials: Inventory Growth and Balance Sheet Update - Kalkine Media
CapsoVision Q2 Results: Revenue rises 10% to $3.6 million - scanx.trade
Earnings call transcript: CapsoVision Q2 2026 loss widens as shares fall after hours - Investing.com
CapsoVision Files Mixed Shelf for Up to $250 Million in Securities - marketscreener.com
CapsoVision Q2 2026 Earnings Call Transcript - Benzinga
CapsoVision Launches $100 Million At-the-Market Equity Program - TipRanks
CapsovisionMay Offer Up To $250 Million Of Common Stock, Preferred Stock, Warrants, Rights, And Units - TradingView
CapsoVision (CV) widens losses in H1 2026 and flags going concern risk - Stock Titan
CapsoVision, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
CapsoVision, Inc. Provides Revenue Guidance for the Second Half of 2026 - marketscreener.com
CapsoVision Reports Second Quarter 2026 Financial Results - Yahoo Finance
CapsoVision Inc (CV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CapsoVision Inc (CV) Stock News Today - TradingKey
CV Q1 2026 Earnings: Wider-Than-Expected Loss of $0.15 Per Share, Stock Rises 2.9%Earnings Sentiment Score - careplusvn.com
CapsoVision launches AI feature for capsule endoscopy abroad By Investing.com - Investing.com Canada
CapsoVision® Announces International Launch of AI Highlights - The Manila Times
CapsoVision launches AI feature for capsule endoscopy abroad - Investing.com
CV|CapsoVision Inc|Price:6.580|Chg%:-0.120 - tradingkey.com
Capsovision Inc Stock (CV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.31%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):